Jan 29 (Reuters) - Celgene Corp CELG.O :
* TRIPHASE ACCELERATOR - ENTERED INTO NEW STRATEGIC PARTNERSHIP WITH CELGENE CORPORATION
* TRIPHASE ACCELERATOR - FOCUS OF COLLABORATION TO BE ON PRE-CLINICAL THERAPEUTIC BY OICR FOR LEUKEMIA & OTHER BLOOD CANCERS, SPECIFICALLY TARGETING WDR5 PROTEIN
* TRIPHASE ACCELERATOR- CELGENE TO PAY UPFRONT AMOUNT OF $40 MILLION